Zimmer Biomet Holdings Inc. (ZBH)

112.95
NYSE : Health Technology
Prev Close 112.95
Day Low/High 0.00 / 0.00
52 Wk Low/High 104.28 / 134.55
Avg Volume 1.13M
Exchange NYSE
Shares Outstanding 203.98M
Market Cap 22.85B
EPS 9.00
P/E Ratio 13.04
Div & Yield 0.96 (0.86%)

Latest News

IDEXX Labs, Evolent Health, Triton: 'Mad Money' Lightning Round

IDEXX Labs, Evolent Health, Triton: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at IDEXX Labs, Evolent Health, Triton, Western Gas Partners, Zimmer Biomet and more.

When Sellers Walk Away: Cramer's 'Mad Money' Recap (Tuesday 7/31/18)

When Sellers Walk Away: Cramer's 'Mad Money' Recap (Tuesday 7/31/18)

Jim Cramer says the tide of selling eventually ebbs, and when it does, stocks rally.

Johnson Fistel Announces Investigations Of Zimmer Biomet Holdings, Inc., Acadia Healthcare Company, And Floor & Decor Holdings, Inc.; Investors Encouraged To Contact Firm

Johnson Fistel Announces Investigations Of Zimmer Biomet Holdings, Inc., Acadia Healthcare Company, And Floor & Decor Holdings, Inc.; Investors Encouraged To Contact Firm

SAN DIEGO, Oct. 13, 2018 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential claims against Zimmer Biomet Holdings, Inc.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Jim Cramer: Valuations Now Have No Relation to Common Sense

Jim Cramer: Valuations Now Have No Relation to Common Sense

Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.

Zimmer Biomet Announces Quarterly Dividend For Third Quarter Of 2018

Zimmer Biomet Announces Quarterly Dividend For Third Quarter Of 2018

WARSAW, Ind., Sept.

Zimmer Biomet Holdings Becomes #210 Most Shorted S&P 500 Component, Replacing EQT

Zimmer Biomet Holdings Becomes #210 Most Shorted S&P 500 Component, Replacing EQT

The most recent short interest data has been released for the 08/15/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Zimmer Biomet Appoints Maria Teresa (Tessa) Hilado And Syed Jafry To Board Of Directors

Zimmer Biomet Appoints Maria Teresa (Tessa) Hilado And Syed Jafry To Board Of Directors

Hilado and Jafry Bring Financial Acumen and Global Experience to Board of Directors

Zimmer Biomet Announces Second Quarter 2018 Financial Results

Zimmer Biomet Announces Second Quarter 2018 Financial Results

- Net sales of $2.008 billion for the second quarter represent an increase of 3.0% over the prior year period, and an increase of 1.0% on a constant currency basis

Zimmer Biomet Holdings Announces Audio Webcast And Conference Call Of Second Quarter 2018 Results

Zimmer Biomet Holdings Announces Audio Webcast And Conference Call Of Second Quarter 2018 Results

WARSAW, Ind., June 20, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc.

The New #246 Most Shorted S&P 500 Component: Zimmer Biomet Holdings

The New #246 Most Shorted S&P 500 Component: Zimmer Biomet Holdings

The most recent short interest data has been released for the 05/31/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: HP, PNR, ZBH Downgrades: BEN, BXP, CWBC, IDTI, INOV, MOD, NATI, PII, QTS, RMBS, SONA, TROW, UBSI, UTMD Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Zimmer Biomet Holdings Achieves #56 Analyst Rank, Surpassing Range Resources

Zimmer Biomet Holdings Achieves #56 Analyst Rank, Surpassing Range Resources

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Zimmer Biomet Holdings Inc has taken over the #56 spot from Range Resources Corp , according to ETF Channel. Below is a chart of Zimmer Biomet Holdings Inc versus Range Resources Corp plotting their respective rank within the S&P 500 over time (ZBH plotted in blue; RRC plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.

Stocks That Gain From New Tax Law: Cramer's 'Mad Money' Recap (Wed 12/20/17)

Stocks That Gain From New Tax Law: Cramer's 'Mad Money' Recap (Wed 12/20/17)

Which stocks fit the 'profile'? They benefit from the tax overhaul and are under-loved by Wall Street, says Jim Cramer.

A Drug Giant, a Maker of Artificial Joints and Other Stocks That Look Good Short

MRK, PEGA, FNGN, RGNX and ZBH all recently were downgraded by TheStreet's Quant Ratings.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ANF, CWCO, DOOR, GCP, OSN, PLT, SJT, TRC Downgrades: FNGN, OPNT, ZBH Initiations: CSTR, DRNA, MPO, MRT Read on to get TheStreet Quant Ratings' detailed report:

Russell 2000 Skips the Party

Number of stocks making new highs keeps climbing.

Don't Get Out of Joint

Don't Get Out of Joint

Demand for artificial joints is growing, and Zimmer Biomet is a good way to play the demographic trend.

Zimmer Biomet: Cramer's Top Takeaways

Zimmer Biomet: Cramer's Top Takeaways

Jim Cramer says sometimes a company can have a great long-term story, but management fails to deliver.

Market Stands at a Make-Or-Break Level: Cramer's 'Mad Money' Recap (Monday 7/17/17)

Market Stands at a Make-Or-Break Level: Cramer's 'Mad Money' Recap (Monday 7/17/17)

Jim Cramer says the earnings results we get this week will determine where stocks are headed for the rest of the quarter.

Zimmer Biomet Stock Jumps After Jana Said to Have Taken Significant Stake

Zimmer Biomet Stock Jumps After Jana Said to Have Taken Significant Stake

While the size of the stake is unclear, Jana's Nirvana Offshore Fund recently received an Early Termination Notice from the FTC, allowing the firm to increase its stake.

Zimmer Biomet Holdings Becomes #139 Most Shorted S&P 500 Component, Replacing Target

The most recent short interest data has been released for the 04/13/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Cramer: We Have Nothing to Distinguish the Stocks Right Now

Cramer: We Have Nothing to Distinguish the Stocks Right Now

We know that we are in the era when index managers are ascendant.

Impax Gains 38% On CEO Appointment, Talk of Sale

Impax Gains 38% On CEO Appointment, Talk of Sale

The company hired Paul Bisaro, former chairman at Allergan, to become CEO as Morgan Stanley helps explore alternatives, including a sale.

Zimmer Biomet Holdings Becomes #187 Most Shorted S&P 500 Component, Replacing L3 Technologies

The most recent short interest data has been released for the 03/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

4 Health Care Charts Signaling Buys: Pfizer, Amgen Included

4 Health Care Charts Signaling Buys: Pfizer, Amgen Included

Obamacare? Trumpcare? These stocks don't care.

TheStreet Quant Rating: B- (Buy)